This Tribe Public Webinar Presentation and Q&A Event was held Tuesday, October 13th Steven Quay, MD, PhD, CEO & Founder & Kyle Guse CFO of Atossa Therepeutics (NASDAQ: ATOS) who delivered a presentation titled “Atossa Therapeutics: Tackling our Greatest Health Challenges – COVID-19 and Breast Cancer.”
Dr. Quay is an author, entrepreneur, and accomplished physician-scientist that has founded six startups invented seven FDA-approved pharmaceuticals and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. He received his M.D., M.A., and Ph.D. from The University of Michigan. He was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana and a resident at the Harvard-Massachusetts General Hospital. He was on the faculty of Stanford University School of Medicine for almost a decade.
Atossa Therapeutics (NASDAQ: ATOS), is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19.
Members from around the world of Tribe Public receive regular FREE invitations for Presentation and Q&A Events from Tribe Public www.tribepublic.com. Members may also express their interest via Tribe “Wish List” process for other speakers, experts, and leaders of industry to present with an emphasis on NYSE and Nasdaq listed companies. Members include investor groups that include institutions, private equity, venture funds, hedge funds, mutual funds, family offices, RIA’s accredited investors, sell side analysts, and members of media.
